首页> 外文期刊>The Journal of laboratory and clinical medicine >Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease.
【24h】

Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease.

机译:小分子铁配合物激活肝细胞中转铁蛋白的铁摄取机制:对铁超载疾病发病机理的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The liver is one of the principal sites of iron overload in diseases such as hemochromatosis and beta thalassemia. Hence, much effort has been invested in examining the mechanisms of Fe uptake by hepatocytes. In the present study we have examined the effect of small molecular weight (M(r)) Fe complexes on Fe uptake from iron 59-labeled transferrin (Tf) and 59Fe-labeled citrate by primary cultures of hepatocytes. This was important to assess because Fe-citrate and saturated diferric Tf coexist in the serum of patients with untreated Fe overload. Preincubation of hepatocytes with the low-M(r) Fe complex ferric ammonium citrate (FAC; 25 microg/mL; (Fe) = 4.4 microg/mL) followed by incubation with 59Fe-Tf or 59Fe-citrate ((Fe) = 0.25 to 25 micromol/L) resulted in the marked stimulation of 59Fe uptake. For example, at a physiologically relevant Tf-Fe concentration of 25 micromol/L, there was an 8-fold increase in 59Fe uptake by cells incubated with FAC compared to control cells. In contrast, at Tf-Fe concentrations of 0.25 to 2.5 micromol/L, 59Fe uptake in FAC-treated cells was only 1-fold to 3-fold greater than that in the corresponding controls. These data suggest that the FAC-activated Fe uptake process predominates at physiologically relevant Tf concentrations above the saturation of the Tf receptor (TfR). This is the first study to demonstrate that preincubation of hepatocytes with Iow-M(r)Fe complexes can markedly increase Fe uptake from diferric Tf. In conclusion, these results may help to explain the loading of hepatocytes with Fe that occurs in Fe-overload disease despite marked down-regulation of the TfR.
机译:在诸如血色素沉着症和β地中海贫血等疾病中,肝脏是铁超负荷的主要部位之一。因此,在检查肝细胞摄取铁的机制上已经投入了很多精力。在本研究中,我们研究了小分子量(M(r))铁配合物对肝细胞原代培养物从铁59标记的转铁蛋白(Tf)和59Fe标记的柠檬酸盐中摄取铁的影响。这一点很重要,因为未经治疗的铁超负荷患者的血清中会同时存在柠檬酸铁和饱和二铁Tf。将肝细胞与低M(r)Fe复合柠檬酸铁铵铵(FAC; 25 microg / mL;(Fe)= 4.4 microg / mL)预孵育,然后与59Fe-Tf或59Fe-柠檬酸盐((Fe)= 0.25)孵育到25μmol/ L)显着刺激了59Fe的吸收。例如,在生理相关的Tf-Fe浓度为25 micromol / L时,与对照细胞相比,用FAC孵育的细胞的59Fe吸收量增加了8倍。相反,在Tf-Fe浓度为0.25至2.5 micromol / L的情况下,FAC处理的细胞中59Fe的吸收量仅是相应对照的1倍至3倍。这些数据表明,在高于Tf受体(TfR)饱和的生理相关Tf浓度下,FAC激活的Fe吸收过程占主导地位。这是第一项证明肝细胞与Iow-M(r)Fe复合物的预孵育可以显着增加二价Tf吸收Fe的研究。总之,尽管TfR明显下调,但这些结果可能有助于解释在Fe超负荷疾病中发生的Fe肝细胞负荷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号